• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠易激综合征和炎症性肠病疲劳的比较特征:系统评价和荟萃分析。

Comparative characteristics of fatigue in irritable bowel syndrome and inflammatory bowel disease: A systematic review and meta-analysis.

机构信息

Korean Medical College of Daejeon University, 62, Daehak-ro, Dong-gu, Daejeon 34520, Republic of Korea.

Research Center for CFS/ME, Daejeon Oriental Hospital of Daejeon University, 176 Daedeokdae-ro, Seo-gu, Daejeon 35235, Republic of Korea.

出版信息

J Psychosom Res. 2024 Feb;177:111589. doi: 10.1016/j.jpsychores.2024.111589. Epub 2024 Jan 6.

DOI:10.1016/j.jpsychores.2024.111589
PMID:38199049
Abstract

OBJECTIVE

Fatigue is a common symptom in both irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC). This study aimed to distinguish fatigue characteristics in IBS and IBD, two functional and organic disorders.

METHODS

We systematically searched the PubMed and Cochrane Library databases from inception to June 30, 2023, and conducted a meta-analysis to generate precise estimates and 95% confidence intervals. The analyses were stratified by fatigue type, severity, sex, disease phase, and comorbidities, and study quality was assessed using Newcastle-Ottawa Scale (NOS).

RESULTS

Our analysis included 74 data (13 IBS, 31 CD, 30 UC) encompassing 16,689 participants (6484 males, 7402 females, and 2803 unknown). Overall, fatigue prevalence trended higher in IBS (54.5% [95%CI, 44.5-64.6]), followed by CD (49.8% [95%CI, 44.0-55.5]) and UC (43.6% [95%CI, 38.5-48.7]). This pattern persisted across sub-analyses, including general fatigue (63.4% vs. 51.3% vs. 45.3%) and moderate to severe fatigue (73.8% vs. 59.5% vs. 52.7%) for IBS, CD, and UC, respectively. Female predominance was observed in all three diseases (odds ratio: 1.5 in IBS and CD, 1.8 in UC). Fatigue prevalence significantly varied between disease phases (active vs. remission) in CD (61.3% vs. 36.3%) and UC (53.8% vs. 32.6%). Anemia, anxiety/depression, and/or IBS-like symptoms also contributed to fatigue in CD and UC.

CONCLUSIONS

This study is the first extensive comparison of fatigue prevalence and features in IBS, CD, and UC. The findings offer valuable insights for treatment and management, aiding our understanding of functional and organic diseases.

摘要

目的

疲劳是肠易激综合征(IBS)和炎症性肠病(IBD)的常见症状,包括克罗恩病(CD)和溃疡性结肠炎(UC)。本研究旨在区分 IBS 和 IBD 的疲劳特征,这两种疾病分别是功能性和器质性疾病。

方法

我们系统地检索了 PubMed 和 Cochrane Library 数据库,检索时间截至 2023 年 6 月 30 日,并进行了荟萃分析,以生成精确的估计值和 95%置信区间。分析按疲劳类型、严重程度、性别、疾病阶段和合并症进行分层,并使用纽卡斯尔-渥太华量表(NOS)评估研究质量。

结果

我们的分析包括 74 项数据(13 项 IBS、31 项 CD、30 项 UC),涵盖了 16689 名参与者(6484 名男性、7402 名女性和 2803 名未知性别)。总体而言,IBS 的疲劳患病率较高(54.5%[95%CI,44.5-64.6%]),其次是 CD(49.8%[95%CI,44.0-55.5%])和 UC(43.6%[95%CI,38.5-48.7%])。这一模式在包括一般疲劳(63.4%比 51.3%比 45.3%)和中重度疲劳(73.8%比 59.5%比 52.7%)在内的所有亚分析中均存在,分别适用于 IBS、CD 和 UC。三种疾病均以女性为主(IBS 和 CD 的优势比为 1.5,UC 的优势比为 1.8)。CD(活动期 vs. 缓解期)和 UC(活动期 vs. 缓解期)的疲劳患病率在疾病阶段之间有显著差异(61.3%比 36.3%,53.8%比 32.6%)。贫血、焦虑/抑郁和/或 IBS 样症状也导致 CD 和 UC 出现疲劳。

结论

这是首次对 IBS、CD 和 UC 中疲劳患病率和特征进行的广泛比较。研究结果为治疗和管理提供了有价值的见解,有助于我们理解功能性和器质性疾病。

相似文献

1
Comparative characteristics of fatigue in irritable bowel syndrome and inflammatory bowel disease: A systematic review and meta-analysis.肠易激综合征和炎症性肠病疲劳的比较特征:系统评价和荟萃分析。
J Psychosom Res. 2024 Feb;177:111589. doi: 10.1016/j.jpsychores.2024.111589. Epub 2024 Jan 6.
2
Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis.炎症性肠病中符合肠易激综合征标准的症状患病率:系统评价和荟萃分析。
Am J Gastroenterol. 2012 Oct;107(10):1474-82. doi: 10.1038/ajg.2012.260. Epub 2012 Aug 28.
3
Presence of Irritable Bowel Syndrome Symptoms in Quiescent Inflammatory Bowel Disease Is Associated with High Rate of Anxiety and Depression.肠易激综合征症状在炎症性肠病缓解期的存在与焦虑和抑郁的高发生率相关。
Dig Dis Sci. 2019 Jul;64(7):1923-1928. doi: 10.1007/s10620-019-05488-8. Epub 2019 Feb 6.
4
Prevalence and Impact of Inflammatory Bowel Disease-Irritable Bowel Syndrome on Patient-reported Outcomes in CCFA Partners.炎症性肠病-肠易激综合征在CCFA合作伙伴中对患者报告结局的患病率及影响
Inflamm Bowel Dis. 2017 Feb;23(2):325-331. doi: 10.1097/MIB.0000000000001017.
5
The prevalence of irritable bowel syndrome-type symptoms in paediatric inflammatory bowel disease, and the relationship with biochemical markers of disease activity.儿童炎症性肠病中肠易激综合征样症状的流行情况,及其与疾病活动的生化标志物的关系。
Aliment Pharmacol Ther. 2016 Jul;44(2):181-8. doi: 10.1111/apt.13636. Epub 2016 Apr 25.
6
Comparison of comorbid depression between irritable bowel syndrome and inflammatory bowel disease: A meta-analysis of comparative studies.比较肠易激综合征和炎症性肠病的共病性抑郁:比较研究的荟萃分析。
J Affect Disord. 2018 Sep;237:37-46. doi: 10.1016/j.jad.2018.04.111. Epub 2018 May 4.
7
Efficacy and safety of biophenol-rich nutraceuticals in adults with inflammatory gastrointestinal diseases or irritable bowel syndrome: A systematic literature review and meta-analysis.富含生物酚的营养保健品在炎症性胃肠道疾病或肠易激综合征成人患者中的疗效和安全性:系统文献回顾和荟萃分析。
Nutr Diet. 2022 Feb;79(1):76-93. doi: 10.1111/1747-0080.12672. Epub 2021 May 7.
8
Comparison of geographic distributions of Irritable Bowel Syndrome with Inflammatory Bowel Disease fail to support common evolutionary roots: Irritable Bowel Syndrome and Inflammatory Bowel Diseases are not related by evolution.肠易激综合征和炎症性肠病的地理分布比较不能支持共同的进化根源:肠易激综合征和炎症性肠病在进化上没有关系。
Med Hypotheses. 2018 Jan;110:31-37. doi: 10.1016/j.mehy.2017.10.020. Epub 2017 Nov 2.
9
Association of fatigue with disease activity and clinical manifestations in patients with Crohn's disease and ulcerative colitis: an observational cross-sectional study in the United States.炎症性肠病患者疲劳与疾病活动和临床表现的相关性:美国的一项观察性横断面研究。
Curr Med Res Opin. 2024 Sep;40(9):1537-1544. doi: 10.1080/03007995.2024.2380733. Epub 2024 Aug 1.
10
Prevalence of irritable bowel syndrome-like symptoms using Rome IV criteria in patients with inactive inflammatory bowel disease and relation with quality of life.采用罗马IV标准评估非活动性炎症性肠病患者中肠易激综合征样症状的患病率及其与生活质量的关系。
Medicine (Baltimore). 2020 May;99(19):e20067. doi: 10.1097/MD.0000000000020067.

引用本文的文献

1
Fatigue Is Strongly Associated with Depressive Symptoms in Patients with Inflammatory Bowel Disease.疲劳与炎症性肠病患者的抑郁症状密切相关。
Inflamm Intest Dis. 2025 Apr 2;10(1):90-103. doi: 10.1159/000545572. eCollection 2025 Jan-Dec.
2
[Functional disorders in chronic inflammatory bowel disease: the gut-brain axis].[慢性炎症性肠病中的功能障碍:肠-脑轴]
Inn Med (Heidelb). 2025 Feb;66(2):181-189. doi: 10.1007/s00108-024-01832-x. Epub 2025 Jan 14.
3
Fatigue in Patients with Inflammatory Bowel Disease in Remission One Year After Diagnosis (the IBSEN III Study).
炎症性肠病患者确诊一年后缓解期的疲劳(IBSEN III研究)
J Crohns Colitis. 2025 Apr 4;19(4). doi: 10.1093/ecco-jcc/jjae170.
4
Comparative study for fatigue prevalence in subjects with diseases: a systematic review and meta-analysis.疾病患者疲劳患病率的对比研究:系统评价和荟萃分析。
Sci Rep. 2024 Oct 7;14(1):23348. doi: 10.1038/s41598-024-74683-z.
5
Association between depression and anxiety with the risk and flare of inflammatory bowel disease: a systematic review and meta-analysis.抑郁症和焦虑症与炎症性肠病的风险及发作之间的关联:一项系统评价和荟萃分析。
Intern Emerg Med. 2025 Jan;20(1):35-46. doi: 10.1007/s11739-024-03764-8. Epub 2024 Oct 3.
6
Changes in Digestive Health, Satiety and Overall Well-Being after 14 Days of a Multi-Functional GI Primer Supplement.多功能胃肠道启动补充剂 14 天后消化健康、饱腹感和整体幸福感的变化。
Nutrients. 2024 Sep 19;16(18):3173. doi: 10.3390/nu16183173.
7
[Immunological aspects and stress regulation in fatigue].[疲劳中的免疫学方面与应激调节]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2024 Nov;67(11):1222-1230. doi: 10.1007/s00103-024-03952-z. Epub 2024 Sep 26.
8
Unraveling the fatigue puzzle: insights into the pathogenesis and management of IBD-related fatigue including the role of the gut-brain axis.解开疲劳之谜:深入了解炎症性肠病相关疲劳的发病机制与管理,包括肠-脑轴的作用。
Front Med (Lausanne). 2024 Jul 3;11:1424926. doi: 10.3389/fmed.2024.1424926. eCollection 2024.